NA, S., L, J., AW, S., A, A., V, V., NH, L., . . . HS, P. (2022). Hypofractionated vs. standard radiotherapy for locally advanced limited-stage small cell lung cancer. Journal of thoracic disease, 14(2), 306. https://doi.org/10.21037/jtd-21-1566
Chicago Style (17th ed.) CitationNA, Saeed, Jin L, Sasse AW, Amini A, Verma V, Lester-Coll NH, Chen PH, Decker RH, and Park HS. "Hypofractionated Vs. Standard Radiotherapy for Locally Advanced Limited-stage Small Cell Lung Cancer." Journal of Thoracic Disease 14, no. 2 (2022): 306. https://doi.org/10.21037/jtd-21-1566.
MLA (9th ed.) CitationNA, Saeed, et al. "Hypofractionated Vs. Standard Radiotherapy for Locally Advanced Limited-stage Small Cell Lung Cancer." Journal of Thoracic Disease, vol. 14, no. 2, 2022, p. 306, https://doi.org/10.21037/jtd-21-1566.